Impruvon Partners with Missouri to Enhance Medication Management and Reduce Errors Statewide

Impruvon Unites with Missouri for Enhanced Medication Management



Impruvon, renowned for its innovative solutions in medication management, has recently joined forces with the Missouri Department of Mental Health's Division of Developmental Disabilities (DDD). This strategic partnership aims to implement Impruvon's Electronic Medication Administration Record (eMAR) within Missouri's Medication Administration Program. This initiative not only automates the complex processes of medication management through the integration of Health Risk Screening Tools (HRST) but also enhances the accuracy of medical records for individuals with intellectual and developmental disabilities (I/DD).

The Need for Improved Medication Management



For vulnerable populations, the precision of medication management is essential. Mistakes in administering medication can severely compromise an individual’s quality of life, possibly exacerbating existing conditions or leading to unnecessary hospital visits. Impruvon's approach focuses on minimizing these errors, thereby contributing to the overall well-being of patients while alleviating pressures on the state's healthcare and support systems.

Voices Behind the Partnership



In the words of Justin Amoyal, CEO and Co-Founder of Impruvon, "We are grateful to chart this path to statewide compliance together, with the incredible people at the Missouri Department of Mental Health and its constituent agencies. Every profession and industry needs their tools, and Missouri is leading the charge for residential HCBS providers to get theirs.” This sentiment underscores the shared mission to not only comply with state regulations but also to improve operational efficiencies.

Moreover, Brit Keller, Impruvon’s Chief Customer Officer, expressed a vision that extends beyond mere compliance, stating, “Our goal is not only compliance but to simplify workflows, reduce medication errors, support staff retention, and ultimately improve outcomes for the individuals Missouri providers serve every day.”

Impact on Service Providers



With more than 500 provider program sites across residential, day, and community-based settings eligible for the Impruvon platform rollout, this partnership is expected to bring substantial change. The widespread adoption of eMAR technology in these facilities signifies a monumental shift in how medication management is conducted for individuals who often cannot advocate for themselves.

Upcoming Exhibit at Starling Conference



In a step to further engage with the community of providers, Impruvon plans to showcase its innovative advancements during the Starling Conference set to take place in Branson, Missouri, from November 17–18, 2026. Attendees will have the opportunity to interact with Impruvon representatives who will elucidate the benefits and functions of the electronic medication administration record (eMAR) system.

About Impruvon



As a trusted partner for both healthcare providers and governmental organizations, Impruvon stands at the forefront of proactive medication management and care coordination tailored specifically for I/DD, behavioral health, and home and community-based service (HCBS) environments. Their technology, comprising an integrated suite of eMAR, smart medication storage solutions, and pharmacy integrations, works to eliminate medication errors and ease administrative burdens while enhancing health outcomes for the underserved.

In conclusion, the collaboration between Impruvon and the Missouri Department of Mental Health marks a significant advancement in the endeavor to provide better healthcare solutions for some of Missouri's most vulnerable citizens. By leveraging advanced technology and fostering teamwork among various stakeholders, a more systematic approach to medication administration can be achieved, ultimately leading to better life quality for individuals with intellectual and developmental disabilities.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.